Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Apararenone (MT-3995) is a receptor antagonist of mineralocorticoid receptor which can be used to treat non-alcoholic steatohepatitis and diabetic nephropathy.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 14,500 | |||
10 mg | 在庫あり | ¥ 19,500 | |||
25 mg | 在庫あり | ¥ 30,000 | |||
50 mg | 在庫あり | ¥ 43,500 | |||
100 mg | 在庫あり | ¥ 63,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 17,500 |
説明 | Apararenone (MT-3995) is a receptor antagonist of mineralocorticoid receptor which can be used to treat non-alcoholic steatohepatitis and diabetic nephropathy. |
In vivo | A phase II clinical trial has been initiated among patients with non-alcoholic steatohepatitis (NASH) in Japan[1]. |
別名 | MT-3995 |
分子量 | 364.39 |
分子式 | C17H17FN2O4S |
CAS No. | 945966-46-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (343.04 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Apararenone 945966-46-1 Endocrinology/Hormones Glucocorticoid Receptor inhibit Inhibitor MT 3995 Mineralocorticoid Receptor MT3995 MT-3995 inhibitor